Literature DB >> 12828879

Recent advances in temporal arteritis.

Carol Redillas1, Seymour Solomon.   

Abstract

Temporal arteritis was first described in the late nineteenth century. Despite considerable progress in understanding the disease, its rarity in the young and in those who are not of Scandinavian ethnicity remains unexplained. Microbiologic agents and immunologic mechanisms have been implicated as causative factors. Although steroids remain the drug of choice, the use of other immunologic therapies has been proposed. This paper reviews the disease's history, probable etiologies, clinical manifestations, and its diagnostic and treatment challenges.

Entities:  

Mesh:

Year:  2003        PMID: 12828879     DOI: 10.1007/s11916-003-0050-0

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  73 in total

1.  Gadolinium contrast magnetic resonance imaging of the temporal artery in giant cell arteritis.

Authors:  H J Anders; T Sigl; A Sander; E Coppenrath; T Pfluger; H Kellner
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

2.  Giant cell arteritis and pericardial effusion.

Authors:  J V Butler; J Callaghan; S O'Keeffe; E C Mulkerrin
Journal:  Ir Med J       Date:  2001-03

3.  Does dapsone have a role in the treatment of temporal arteritis with regard to efficacy and toxicity?

Authors:  F Liozon; E Vidal; J Barrier
Journal:  Clin Exp Rheumatol       Date:  1993 Nov-Dec       Impact factor: 4.473

4.  Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.

Authors:  M J Kupersmith; R Langer; H Mitnick; R Spiera; H Spiera; M Richmond; S Paget
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

5.  Prevention of serious ophthalmic and cerebral complications in temporal arteritis?

Authors:  D Schmidt; P Vaith; A Hetzel
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

6.  Detection of varicella zoster virus DNA in some patients with giant cell arteritis.

Authors:  B M Mitchell; R L Font
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-10       Impact factor: 4.799

7.  Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.

Authors:  P Cacoub; K Chemlal; P Khalifa; B Wechsler; C De Gennes; N Belmatoug; P Cohen; J M Ziza; B Verdoncq; J C Piette
Journal:  J Rheumatol       Date:  2001-11       Impact factor: 4.666

8.  The importance of skip lesions in temporal arteritis.

Authors:  D N Poller; Q van Wyk; M J Jeffrey
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

9.  Temporal arteritis: a cough, toothache, and tongue infarction.

Authors:  David B Hellmann
Journal:  JAMA       Date:  2002-06-12       Impact factor: 56.272

10.  Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?.

Authors:  Carlo Salvarani; Mauro Silingardi; Angelo Ghirarduzzi; Giovanni Lo Scocco; PierLuigi Macchioni; GianLuigi Bajocchi; Marco Vinceti; Fabrizio Cantini; Ido Iori; Luigi Boiardi
Journal:  Ann Intern Med       Date:  2002-08-20       Impact factor: 25.391

View more
  2 in total

Review 1.  Painful ophthalmoplegia: overview with a focus on Tolosa-Hunt syndrome.

Authors:  Jonathan P Gladstone; David W Dodick
Journal:  Curr Pain Headache Rep       Date:  2004-08

Review 2.  Horton's disease: past and present.

Authors:  Morris Levin; Thomas N Ward
Journal:  Curr Pain Headache Rep       Date:  2005-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.